This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Aleafia Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Aleafia Health şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-69.7%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-69.7%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Apr 19

Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

Jan 04

CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Feb 17

Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Feb 16

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: AH şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: AH şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Aleafia Health Piyasaya Karşı Temettü Getirisi

AH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (AH)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.2%
Sektör Ortalaması (Pharmaceuticals)	2.4%
Analist tahmini (AH) (3 yıla kadar)	n/a

Önemli Temettü: AH şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, AH şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: AH şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: AH herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

This company listing is no longer active

Aleafia Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Price target increased by 47% to CA$0.25

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Aleafia Health Inc. Announces Board Changes

Now 24% undervalued

Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

High number of new and inexperienced directors

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Consensus forecasts updated

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

Consensus EPS estimates fall by 586%

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

Here's Why Aleafia Health (TSE:AH) Can Afford Some Debt

Consensus forecasts updated

Price target decreased to CA$0.70

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

Chief Executive Officer recently bought CA$50k worth of stock

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Consensus forecasts updated

Chief Executive Officer recently bought CA$50k worth of stock

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

Price target decreased to CA$1.06

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Analysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: CA$1.09

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Introducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

New 90-day high: CA$0.60

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

Would Aleafia Health (TSE:AH) Be Better Off With Less Debt?

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share

Aleafia Health Inc. Announces Successful Outdoor Harvest Accelerates Product Portfolio Expansion

Aleafia Health Inc. to Report Q3, 2020 Results on Nov 11, 2020

Aleafia Health Inc. Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations

New 90-day low: CA$0.46